Bridge Biotherapeutics will present the phase 1 clinical trial’s result of BBT-176, the fourth-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) drug, at the World Conference on Lung Cancer (WCLC) in Vienna next month.The conference organizers made public the abstract
Biomarker-based new drug developer MedPacto has applied to the U.S. Food and Drug Administration for the investigational new drug (IND) clinical trial of Vactosertib as a solo therapy for recurrent and intractable osteosarcoma patients.This upcoming clinical trial, a phase 1/2 trial of Vactosertib a
Neoimmuntech said Wednesday that the U.S. Food and Drug Administration has granted an orphan drug designation (ODD) for NT-I7, its immunotherapy candidate that treats glioblastoma multiforme (GBM), a type of brain cancer.It was the fourth ODD designation for NT-I7. It also received ODD designations
SK Bioscience’s SKYCovione, Korea's first locally developed Covid-19 vaccine, has shown cross-neutralizing activity against Omicron variant BA.1 as a booster shot administered after the primary vaccination, the company said Wednesday."Amid the rising possibility of the resurgence of Covid-19, we hav
Boehringer Ingelheim and Eli Lilly aim to dominate the chronic heart failure market with Jardiance, a Sodium-Glucose Co-Transporter 2 (SGLT-2) inhibitor drug, armed with an expanded indication in treating heart failure with preserved ejection fraction (HFpEF).HFpEF is a clinical syndrome in which pa
Korea’s daily Covid-19 tally surged to a two-month high of over 37,000 on Tuesday, as the BA.5, an Omicron subvariant, showed signs of becoming a dominant strain.The nation added 37,360 Covid-19 infections on Tuesday, bringing the total caseload to 18,561,861, the Korea Disease Control and Preventio
CBC Group, a Singapore-based venture capital firm that invests in medical and pharmaceutical companies, may fully acquire Hugel and take the company private, Bloomberg reported.A person familiar with the matter, asking for anonymity due to the issue's sensitivity, told the media outlet that CBC is i
Kainos Med said it would start phase 2 clinical trials in the U.S. by administering its Parkinson's disease treatment, KM-819, to subjects.KM-819 is a new drug developed by Kainos Med, which targets FAF, a protein that promotes cell death. It has a dual effect of inhibiting the accumulation of alpha
Sanofi’s fitusiran is called “the dream hemophilia treatment” because it can be used in all hemophilia A or B patients regardless of whether they have inhibitors. In addition, the investigational drug recently proved its prophylaxis effect in a phase 3 study.However, fitusiran reported two thromboem
CHA Vaccine Institute said Monday it has confirmed the immuno-cancer treatment effect of L-pampo, an immuno-cancer drug candidate that stimulates the toll-like receptor (TLR) signal pathway, developed by the institute independently.The institute, jointly with Professors Chon Hong-jae and Kim Chan of
Daiichi Sankyo Korea has received approval from the Ministry of Food and Drug Safety for an additional indication for Taleaje (Ingredient: mirogabalin), a neuropathic pain treatment, in treating central neuropathic pain.Taleaje had previously received approval to treat peripheral neuropathic pain in
JW Pharmaceutical said it has launched a compound digestive medicine, Besticon, and begun marketing activities in earnest.Besticon is a compound digestive medicine composed of alverine citrate, an antispasmodic agent, and simethicone, a degassing agent. It is effective on functional indigestion and
Celltrion Pharm’s prescription liver disease treatment Godex Cap. might lose reimbursement because the Health Insurance Review and Assessment Service (HIRA) recently decided to withdraw its insurance benefits. The company appealed the decision immediately.HIRA disclosed the results of the drug reimb
Hugel said Friday that it has obtained product approval from the Spanish Agency of Drugs and Health Products for its botulinum toxin (BTX) formulation, Letybo, which treats forehead wrinkles.With the product approved in Spain, Hugel has obtained a license in 11 European countries. Spain is one of th
The unionized workers of Novo Nordisk Korea held a protest rally in front of the company’s headquarters in southern Seoul on Thursday, after the breakdown of negotiations over wages and cuts in employee incentives.Out of the total 118 unionists, 100 participated in the protest rally, excluding those
Stock analysts maintain a "buy" opinion for Hanmi Pharmaceutical, predicting that the company's earnings will exceed expectations thanks to the high growth of Beijing Hanmi Pharmaceutical and the scheduled launch of its new drugs.Hanmi has recently stood out as one of the few pharma companies that s
Pharmbio said on Thursday that it signed an exclusive domestic supply contract for Macrilen (component: macrimorelin), a new drug to diagnose adult growth hormone deficiency (AGHD), made by Canada-based Aeterna Zentaris.AGHD is a disease that shows various clinical patterns, such as low height, decr
Hanmi Pharmaceutical said Wednesday that the company has relaunched its liver function-enhancing OTC drug, "Silyman Soft Capsule 140" (Silyman), after sharply increasing its internal resorption rate.Silyman is a product that dramatically increases the absorption rate of conventional silymarin prepar
A health expert stressed the importance of introducing more accurate diagnostic tests to identify KRAS G12C mutated non-small cell lung cancer (NSCLC) patients that can receive treatment with Amgen's Lumakras.Lumakras is the first KRAS targeted therapy developed 40 years after researchers discovered
ST Pharm said it was having a pre-IND (investigational new drug) meeting with the U.S. FDA for a phase 2 trial of an HIV drug, after completing the phase 1 study in France.The Kosdaq-listed company aims to develop the world’s first cure for HIV.On Monday, ST Pharm said in a public filing that it rec